Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Yi Fang

10PUBLICATIONS
5CO-AUTHORS
Pharmaceutical delivery technologiesMolecular targetsImmunogenetics (incl. genetic immunology)Dental therapeutics, pharmacology and toxicologyClinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

Sort by Publication Date:
|Oct 09, 2025
A Multicenter, Randomized, Open-Label, Active-Controlled, Parallel-Group Study Evaluating the Pharmacokinetics of Single-Dose Tapentadol Hydrochloride Intravenous Infusion and Tapentadol Hydrochloride Oral Tablets in Patients with Pain.

Zhiqin Hu, Tenghua Wang, Xiaoqiang Li

|Dec 23, 2024
Efficacy and Safety of Janus Kinase Inhibitors in Patients with Vitiligo: A Systematic Review and Meta-Analysis.

Fan Huang, Dingyuan Hu, Huaying Fan

|Apr 02, 2024
A Phase I Clinical Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of GB221 Injection and Trastuzumab (Herceptin<sup>®</sup>) in Healthy Chinese Adults.

Yu Zhu, Chen Li, Liming Chen

|Nov 21, 2023
An exploratory study of drug concentration and inhibitory effect of cetylpyridinium chloride buccal tablets on SARS-CoV-2 infection among 10 Chinese subjects.

Yanting Li, Zhenwei Xie, Liming Chen

|Nov 13, 2023
First-in-human trial of SAR107375E, a novel small molecule anticoagulant with dual inhibition of factor Xa and factor IIa.

Shuanzhi Wu, Tenghua Wang, Jieyun Li

|Jun 06, 2023
Phase I, Randomized, Placebo-Controlled, Dose-Escalation Study of GB223, a Fully-Humanized Monoclonal Antibody to RANKL, in Healthy Chinese Adults.

Chen Li, Haiyan Liu, Yixiang Liao

Pageof 2

Frequent Collaborators

3 joint publications

Jiaxue Wang

1 joint publications

Shuanzhi Wu

1 joint publications

Dingyuan Hu

1 joint publications

Diqin Yan

1 joint publications

Xiaoyan Nie

Frequent Collaborators

3 joint publications

Jiaxue Wang

1 joint publications

Shuanzhi Wu

1 joint publications

Dingyuan Hu

1 joint publications

Diqin Yan

Top Related Videos

Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on : Apr 09, 2019

5.8K
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

993
A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research
08:17

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

Published on : Aug 15, 2019

14.4K
See more related videos

Top Related Videos

Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on : Apr 09, 2019

5.8K
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

993
A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research
08:17

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

Published on : Aug 15, 2019

14.4K
See more related videos